A Phase I/II Clinical Trial of Temsirolimus plus Neratinib for Patients with Metastatic HER2-Amplified or Triple-Negative Breast Cancer
[Protocol 10-005] |
Chandarlapaty, Sarat |
|
Molecular Mechanisms of Clinical Resistance to Anti-HER2 Therapy Among Patients with HER2-Amplified Breast Cancer
[Protocol 06-163] |
Chandarlapaty, Sarat |
|
A Phase III Study of Vemurafenib in Patients with Surgically Removed BRAF-Mutant Melanoma Who Have a High Risk of Recurrence
[Protocol 12-166] |
Chapman, Paul |
|
A Phase II Study of Dabrafenib After Surgery in Patients with BRAF V600 Mutation-Positive Stage IIIC Melanoma
[Protocol 12-124] |
Chapman, Paul |
|
Molecular Characterization of Neuroblastic Tumors and Clinical Outcome
[Protocol 00-109] |
Cheung, Nai-Kong |
|
A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration
[Protocol 05-001] |
Chi, Dennis |
- Bladder Cancer
- Cervical Cancer
- Colorectal Cancer
- Endometrial and other Uterine Cancers
- Ovarian Cancer
- Survivorship
- Vulvar Cancer
|
A Phase II Study of Secondary Cytoreduction with and without HIPEC plus Postoperative Chemotherapy for Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-275] |
Chi, Dennis |
|
A Pilot Study Assessing PET Probes to Detect Cancerous Tissue During Surgery for Recurrent Ovarian Cancer
[Protocol 13-017] |
Chi, Dennis |
|
Electronic Patient-Reported Outcomes from Home in Patients Recovering from Major Gynecologic Cancer Surgery: Measuring Symptoms and Quality of Life
[Protocol 08-155] |
Chi, Dennis |
- Cervical Cancer
- Endometrial and other Uterine Cancers
- Endometrial Cancer
- Uterine Cancer
- Ovarian Cancer
- Vulvar Cancer
|
A Phase II Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma
[Protocol 12-205] |
Chou, Alexander |
|
A Phase II Study of Gemcitabine and Cisplatin before Surgery in Patients with High-Grade Upper Tract Urothelial Carcinoma
[Protocol 10-208] |
Coleman, Jonathan |
|
Inamed Corporation-Style 410 Silicone-Filled Breast Implant Continued Assess Reconstruction/Revision Expansion (CARE) Clinical Study
[Protocol 06-076] |
Cordeiro, Peter |
- Breast Cancer
- Survivorship
|
A Phase II Study of Trebananib (AMG 386) for the Treatment of Inoperable Advanced Angiosarcoma
[Protocol 12-128] |
D'Angelo, Sandra |
|
A Phase III Study of BMS-936558 versus Standard Chemotherapy in Patients with Advanced Melanoma that Progressed Despite Anti-CTLA-4 Therapy
[Protocol 12-254] |
D'Angelo, Sandra |
|
A Phase I/II Study of Everolimus and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Non-Muscle-Invasive Bladder Cancer
[Protocol 10-165] |
Dalbagni, Guido |
|
A Phase III Study of Chemotherapy and Trastuzumab with or without Pertuzumab in Patients with Operable HER2-Positive Breast Cancer
[Protocol 12-115] |
Dang, Chau |
|
A Phase II Study of Paclitaxel, Trastuzumab, and Pertuzumab for the Treatment of Metastatic HER2-Positive Breast Cancer
[Protocol 10-142] |
Dang, Chau |
|
A Study Assessing the Feasibility of Treatment with Paclitaxel, Trastuzumab, and Lapatinib in Women with HER2-Positive Early-Stage Breast Cancer
[Protocol 13-002] |
Dang, Chau |
|
A Phase I/II Study of Ipilimumab Given with Abiraterone and Prednisone in Men with Metastatic Castration-Resistant Prostate Cancer
[Protocol 12-120] |
Danila, Daniel |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
A Phase I Study of DSTP3086S in Patients with Metastatic Castration-Resistant Prostate Cancer
[Protocol 11-016] |
Danila, Daniel |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
